Clinical Trials List
2022-07-06 - 2025-05-31
Others
Not yet recruiting5
Recruiting1
ICD-10C45.9
Mesothelioma, unspecified
ICD-10C79.9
Secondary malignant neoplasm of unspecified site
ICD-10C7A.00
Malignant carcinoid tumor of unspecified site
ICD-10C7A.094
Malignant carcinoid tumor of the foregut NOS
ICD-10C7A.095
Malignant carcinoid tumor of the midgut NOS
ICD-10C7A.096
Malignant carcinoid tumor of the hindgut NOS
ICD-10C7A.1
Malignant poorly differentiated neuroendocrine tumors
ICD-10C7A.8
Other malignant neuroendocrine tumors
ICD-10C7B.00
Secondary carcinoid tumors, unspecified site
ICD-10C80.1
Malignant (primary) neoplasm, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9199.1
Malignant neoplasm of unspecified site (primary) (secondary)
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Hung-Chih Hsu 無
- 徐執中 無
- Jen-Shi Chen 無
- Po-Jung Su 無
- Tsai-Sheng Yang 無
- 余紹銘 無
- Ming-Mo Hou 無
- 陳建銘 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Mei-Ju Chen 無
- Huann-Cheng Horng 無
- Yi-Jen Chen 無
- Yen-Hou Chang 無
- 沈書慧 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 林宗哲 無
- 張端瑩 無
- Chih-Hung Hsu 無
- YU-YUN SHAO 無
- 莊建淮 無
- Chiun Hsu 無
- 陳國興 無
- Hsin-Yu Liu 無
- Kun-Huei Yeh 無
- Ying-Chun Shen 無
- 黃柏翔 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 劉奕廷 無
- Keng-Fu Hsu 無
- Yu-Min Yeh 無
- Chien-Jui Huang 無
- 顏志傑 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
120 participants
